Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PJP vs. RSPH: which is better?

Bottom line

PJP vs RSPH: the short answer

PJP (Invesco Pharmaceuticals ETF) and RSPH (Invesco S&P 500 Equal Weight Health Care ETF) are quite different portfolios: only about 21% of their top holdings (by weight) are shared.

RSPH is cheaper at 0.4% vs 0.58% — a difference of $18 a year per $10,000 invested.

Over five years, PJP returned +9.0% a year vs +4.7% for RSPH.

Updated Nov 19, 2026

PJP vs RSPH side by side

PJPRSPH
TypeETFETF
Fund familyInvescoInvesco
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.58%0.4%
Annual cost per $10k$58$40
10-yr cost on $10k (prospectus)$726$505
Max front loadNoneNone
12b-1 fee——
1-yr return+27.9%+9.3%
5-yr return (annualized)+9.0%+4.7%
10-yr return (annualized)+5.1%+8.2%
Best quarter+18.1%+17.5%
Worst quarter−14.8%−14.3%
Net assets (fund)$472.1M$766.9M
Number of holdings3363
Portfolio turnover36%24%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPJPRSPHDifference
2025+27.9%+9.3%+18.6%
2024+9.7%−0.8%+10.5%
2023−2.2%+3.9%−6.2%
2022−2.0%−9.2%+7.2%
2021+14.5%+23.0%−8.6%
2020+11.2%+18.9%−7.7%
2019+4.7%+25.3%−20.7%
2018−1.7%−0.3%−1.4%
2017+15.3%+23.4%−8.1%
2016−19.3%−4.5%−14.8%

Source: Fund prospectus bar charts

Holdings overlap

6 of PJP's top 25 holdings also appear in RSPH's top 25.

Shared top holdings
HoldingPJPRSPH
Abbott Laboratories5.67%1.83%
AbbVie Inc.5.48%1.73%
Amgen Inc.5.33%1.77%
Regeneron Pharmaceuticals, Inc.3.14%1.96%
Bristol-Myers Squibb Co.2.94%1.82%
Viatris Inc.2.83%1.72%

Source: SEC Form N-PORT

PJP top 10

  1. Invesco Private Prime Fund — 7.93%
  2. Abbott Laboratories — 5.67%
  3. AbbVie Inc. — 5.48%
  4. Amgen Inc. — 5.33%
  5. Johnson & Johnson — 5.18%
  6. Merck & Co., Inc. — 5.06%
  7. Eli Lilly and Co. — 5.02%
  8. Corcept Therapeutics Inc. — 4.96%
  9. Gilead Sciences, Inc. — 4.53%
  10. Pfizer Inc. — 4.50%

RSPH top 10

  1. Bio-Techne Corp. — 2.13%
  2. IQVIA Holdings Inc. — 2.00%
  3. Baxter International Inc. — 1.99%
  4. Regeneron Pharmaceuticals, Inc. — 1.96%
  5. Mettler-Toledo International Inc. — 1.94%
  6. Charles River Laboratories International, Inc. — 1.93%
  7. Veeva Systems Inc. — 1.93%
  8. DaVita Inc. — 1.87%
  9. Moderna, Inc. — 1.85%
  10. Thermo Fisher Scientific Inc. — 1.84%

FAQ

What is the difference between PJP and RSPH?
PJP (Invesco Pharmaceuticals ETF) and RSPH (Invesco S&P 500 Equal Weight Health Care ETF) are quite different portfolios: only about 21% of their top holdings (by weight) are shared. RSPH is cheaper at 0.4% vs 0.58% — a difference of $18 a year per $10,000 invested.
Which is cheaper, PJP or RSPH?
RSPH has the lower expense ratio (0.4%).
Should I own both PJP and RSPH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.